Back to listings
Patent
Lipid Nanoparticle mRNA Delivery System
GenomicPath SciencesListed Mar 9, 2026
Description
Granted patent covering a proprietary ionizable lipid nanoparticle (LNP) formulation optimized for mRNA delivery to hepatocytes. The technology demonstrates 10x improved endosomal escape compared to first-generation LNPs, with validated in vivo efficacy in NHP studies. Broad applications in gene therapy and mRNA vaccine delivery.
Tags
mRNALNPdrug deliverygene therapyvaccines
Technical Details
- Patent Number
- US11,234,876
- Patent Status
- Granted
Asking Price
$12,000,000
About the Seller
Dr. Sarah Mitchell
GenomicPath Sciences
CRISPR researcher with 15+ years in gene editing and patent development.